Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction

Daihiko Hakuno, Masahiro Kimura, Shinji Ito, Junko Satoh, Yasuhiro Nakashima, Takahiro Horie, Yasuhide Kuwabara, Masataka Nishiga, Yuya Ide, Osamu Baba, Hitoo Nishi, Tetsushi Nakao, Tomohiro Nishino, Fumiko Nakazeki, Satoshi Koyama, Ritsuko Hanada, Ruiz R. Randolph, Jin Endo, Takeshi Kimura, Koh Ono

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Acute cardiac rupture and adverse left ventricular (LV) remodeling causing heart failure are serious complications of acute myocardial infarction (MI). While cardio-hepatic interactions have been recognized, their role in MI remains unknown. We treated cultured cardiomyocytes with conditioned media from various cell types and analyzed the media by mass spectrometry to identify α1-microglobulin (AM) as an Akt-activating hepatokine. In mouse MI model, AM protein transiently distributed in the infarct and border zones during the acute phase, reflecting infiltration of AM-bound macrophages. AM stimulation activated Akt, NFκB, and ERK signaling and enhanced inflammation as well as macrophage migration and polarization, while inhibited fibrogenesis-related mRNA expression in cultured macrophages and cardiac fibroblasts. Intramyocardial AM administration exacerbated macrophage infiltration, inflammation, and matrix metalloproteinase 9 mRNA expression in the infarct and border zones, whereas disturbed fibrotic repair, then provoked acute cardiac rupture in MI. Shotgun proteomics and lipid pull-down analysis found that AM partly binds to phosphatidic acid (PA) for its signaling and function. Furthermore, systemic delivery of a selective inhibitor of diacylglycerol kinase α-mediated PA synthesis notably reduced macrophage infiltration, inflammation, matrix metalloproteinase activity, and adverse LV remodeling in MI. Therefore, targeting AM signaling could be a novel pharmacological option to mitigate adverse LV remodeling in MI.

Original languageEnglish
Article number16749
JournalScientific reports
Volume8
Issue number1
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Myocardial Infarction
Inflammation
Macrophages
Ventricular Remodeling
Heart Rupture
Phosphatidic Acids
Diacylglycerol Kinase
Messenger RNA
Matrix Metalloproteinase 9
Firearms
Conditioned Culture Medium
Matrix Metalloproteinases
Cardiac Myocytes
Proteomics
Mass Spectrometry
Heart Failure
Fibroblasts
Pharmacology
Lipids
Liver

ASJC Scopus subject areas

  • General

Cite this

Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction. / Hakuno, Daihiko; Kimura, Masahiro; Ito, Shinji; Satoh, Junko; Nakashima, Yasuhiro; Horie, Takahiro; Kuwabara, Yasuhide; Nishiga, Masataka; Ide, Yuya; Baba, Osamu; Nishi, Hitoo; Nakao, Tetsushi; Nishino, Tomohiro; Nakazeki, Fumiko; Koyama, Satoshi; Hanada, Ritsuko; Randolph, Ruiz R.; Endo, Jin; Kimura, Takeshi; Ono, Koh.

In: Scientific reports, Vol. 8, No. 1, 16749, 01.12.2018.

Research output: Contribution to journalArticle

Hakuno, D, Kimura, M, Ito, S, Satoh, J, Nakashima, Y, Horie, T, Kuwabara, Y, Nishiga, M, Ide, Y, Baba, O, Nishi, H, Nakao, T, Nishino, T, Nakazeki, F, Koyama, S, Hanada, R, Randolph, RR, Endo, J, Kimura, T & Ono, K 2018, 'Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction', Scientific reports, vol. 8, no. 1, 16749. https://doi.org/10.1038/s41598-018-35194-w
Hakuno, Daihiko ; Kimura, Masahiro ; Ito, Shinji ; Satoh, Junko ; Nakashima, Yasuhiro ; Horie, Takahiro ; Kuwabara, Yasuhide ; Nishiga, Masataka ; Ide, Yuya ; Baba, Osamu ; Nishi, Hitoo ; Nakao, Tetsushi ; Nishino, Tomohiro ; Nakazeki, Fumiko ; Koyama, Satoshi ; Hanada, Ritsuko ; Randolph, Ruiz R. ; Endo, Jin ; Kimura, Takeshi ; Ono, Koh. / Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction. In: Scientific reports. 2018 ; Vol. 8, No. 1.
@article{6141026768a54a16a2dd411969e4d769,
title = "Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction",
abstract = "Acute cardiac rupture and adverse left ventricular (LV) remodeling causing heart failure are serious complications of acute myocardial infarction (MI). While cardio-hepatic interactions have been recognized, their role in MI remains unknown. We treated cultured cardiomyocytes with conditioned media from various cell types and analyzed the media by mass spectrometry to identify α1-microglobulin (AM) as an Akt-activating hepatokine. In mouse MI model, AM protein transiently distributed in the infarct and border zones during the acute phase, reflecting infiltration of AM-bound macrophages. AM stimulation activated Akt, NFκB, and ERK signaling and enhanced inflammation as well as macrophage migration and polarization, while inhibited fibrogenesis-related mRNA expression in cultured macrophages and cardiac fibroblasts. Intramyocardial AM administration exacerbated macrophage infiltration, inflammation, and matrix metalloproteinase 9 mRNA expression in the infarct and border zones, whereas disturbed fibrotic repair, then provoked acute cardiac rupture in MI. Shotgun proteomics and lipid pull-down analysis found that AM partly binds to phosphatidic acid (PA) for its signaling and function. Furthermore, systemic delivery of a selective inhibitor of diacylglycerol kinase α-mediated PA synthesis notably reduced macrophage infiltration, inflammation, matrix metalloproteinase activity, and adverse LV remodeling in MI. Therefore, targeting AM signaling could be a novel pharmacological option to mitigate adverse LV remodeling in MI.",
author = "Daihiko Hakuno and Masahiro Kimura and Shinji Ito and Junko Satoh and Yasuhiro Nakashima and Takahiro Horie and Yasuhide Kuwabara and Masataka Nishiga and Yuya Ide and Osamu Baba and Hitoo Nishi and Tetsushi Nakao and Tomohiro Nishino and Fumiko Nakazeki and Satoshi Koyama and Ritsuko Hanada and Randolph, {Ruiz R.} and Jin Endo and Takeshi Kimura and Koh Ono",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-35194-w",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction

AU - Hakuno, Daihiko

AU - Kimura, Masahiro

AU - Ito, Shinji

AU - Satoh, Junko

AU - Nakashima, Yasuhiro

AU - Horie, Takahiro

AU - Kuwabara, Yasuhide

AU - Nishiga, Masataka

AU - Ide, Yuya

AU - Baba, Osamu

AU - Nishi, Hitoo

AU - Nakao, Tetsushi

AU - Nishino, Tomohiro

AU - Nakazeki, Fumiko

AU - Koyama, Satoshi

AU - Hanada, Ritsuko

AU - Randolph, Ruiz R.

AU - Endo, Jin

AU - Kimura, Takeshi

AU - Ono, Koh

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Acute cardiac rupture and adverse left ventricular (LV) remodeling causing heart failure are serious complications of acute myocardial infarction (MI). While cardio-hepatic interactions have been recognized, their role in MI remains unknown. We treated cultured cardiomyocytes with conditioned media from various cell types and analyzed the media by mass spectrometry to identify α1-microglobulin (AM) as an Akt-activating hepatokine. In mouse MI model, AM protein transiently distributed in the infarct and border zones during the acute phase, reflecting infiltration of AM-bound macrophages. AM stimulation activated Akt, NFκB, and ERK signaling and enhanced inflammation as well as macrophage migration and polarization, while inhibited fibrogenesis-related mRNA expression in cultured macrophages and cardiac fibroblasts. Intramyocardial AM administration exacerbated macrophage infiltration, inflammation, and matrix metalloproteinase 9 mRNA expression in the infarct and border zones, whereas disturbed fibrotic repair, then provoked acute cardiac rupture in MI. Shotgun proteomics and lipid pull-down analysis found that AM partly binds to phosphatidic acid (PA) for its signaling and function. Furthermore, systemic delivery of a selective inhibitor of diacylglycerol kinase α-mediated PA synthesis notably reduced macrophage infiltration, inflammation, matrix metalloproteinase activity, and adverse LV remodeling in MI. Therefore, targeting AM signaling could be a novel pharmacological option to mitigate adverse LV remodeling in MI.

AB - Acute cardiac rupture and adverse left ventricular (LV) remodeling causing heart failure are serious complications of acute myocardial infarction (MI). While cardio-hepatic interactions have been recognized, their role in MI remains unknown. We treated cultured cardiomyocytes with conditioned media from various cell types and analyzed the media by mass spectrometry to identify α1-microglobulin (AM) as an Akt-activating hepatokine. In mouse MI model, AM protein transiently distributed in the infarct and border zones during the acute phase, reflecting infiltration of AM-bound macrophages. AM stimulation activated Akt, NFκB, and ERK signaling and enhanced inflammation as well as macrophage migration and polarization, while inhibited fibrogenesis-related mRNA expression in cultured macrophages and cardiac fibroblasts. Intramyocardial AM administration exacerbated macrophage infiltration, inflammation, and matrix metalloproteinase 9 mRNA expression in the infarct and border zones, whereas disturbed fibrotic repair, then provoked acute cardiac rupture in MI. Shotgun proteomics and lipid pull-down analysis found that AM partly binds to phosphatidic acid (PA) for its signaling and function. Furthermore, systemic delivery of a selective inhibitor of diacylglycerol kinase α-mediated PA synthesis notably reduced macrophage infiltration, inflammation, matrix metalloproteinase activity, and adverse LV remodeling in MI. Therefore, targeting AM signaling could be a novel pharmacological option to mitigate adverse LV remodeling in MI.

UR - http://www.scopus.com/inward/record.url?scp=85056474728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056474728&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-35194-w

DO - 10.1038/s41598-018-35194-w

M3 - Article

C2 - 30425314

AN - SCOPUS:85056474728

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 16749

ER -